Last updated on November 2019

Lipoic Acid for Progressive Multiple Sclerosis (MS)

Brief description of study

The purpose of the study is to determine if lipoic acid can preserve mobility and protect the brain in progressive forms of multiple sclerosis.

Detailed Study Description

This two-year study will determine if daily oral intake of lipoic acid will prove superior to placebo in reducing injury to the brain and maintaining mobility in progressive MS. Mobility will be assessed with the timed 25-foot walk test and 2-minute timed walk test as well as fall counts. Neuroprotection will be measured by the extent of brain volume loss seen on MRI.

Clinical Study Identifier: NCT03161028

Find a site near you

Start Over

University of Utah

Salt Lake City, UT United States
  Connect »